Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Frontiers in Cardiovascular Medicine|December 15, 2015
Structure, Function, Pharmacology, and Therapeutic Potential of the G Protein, Gα/q,11Danielle Kamato, Lyna Thach, Rebekah Bernard, et al.
The International Journal of Biochemistry & Cell Biology|February 14, 2012
G protein coupled receptor transactivation: extending the paradigm to include serine/threonine kinase receptorsMicah L Burch, Narin Osman, Robel Getachew, et al.
Pharmacology & Therapeutics|February 19, 2018
Signalling pathways regulating galactosaminoglycan synthesis and structure in vascular smooth muscle: Implications for lipoprotein binding and atherosclerosisRizwana Afroz, Yingnan Cao, Muhamad Ashraf Rostam, et al.
Drug Metabolism Letters|June 10, 2016
An Investigation of Sodium Fusidate and Recombinant Cytochrome P450 Enzymes Inhibition In-VitroJohn Mishriky, Jacqueline Balassone, Zenah Bashour, et al.
Cellular and Molecular Life Sciences : CMLS|November 12, 2014
The expansion of GPCR transactivation-dependent signalling to include serine/threonine kinase receptors represents a new cell signalling frontierDanielle Kamato, Muhamad Ashraf Rostam, Rebekah Bernard, et al.
Cardiovascular Diabetology|April 16, 2014
Atherogenic, fibrotic and glucose utilising actions of glucokinase activators on vascular endothelium and smooth muscleSefaa Al-aryahi, Danielle Kamato, Robel Getachew, et al.
The Journal of Biological Chemistry|June 24, 2010
Thrombin stimulation of proteoglycan synthesis in vascular smooth muscle is mediated by protease-activated receptor-1 transactivation of the transforming growth factor beta type I receptorMicah L Burch, Mandy L Ballinger, Sundy N Y Yang, et al.
Plos One|July 19, 2017
RNA sequencing to determine the contribution of kinase receptor transactivation to G protein coupled receptor signalling in vascular smooth muscle cellsDanielle Kamato, Venkata Vijayanand Bhaskarala, Nitin Mantri, et al.
Endocrinology|July 9, 2010
PDGF beta-receptor kinase activity and ERK1/2 mediate glycosaminoglycan elongation on biglycan and increases binding to LDLRobel Getachew, Mandy L Ballinger, Micah L Burch, et al.
The Journal of Pharmacy and Pharmacology|June 7, 2013
Suramin inhibits PDGF-stimulated receptor phosphorylation, proteoglycan synthesis and glycosaminoglycan hyperelongation in human vascular smooth muscle cellsPeter J Little, Muhamad Ashraf Rostam, Terrence J Piva, et al.
Pageof 6